Financial statements Arion Pharma
Balance sheet data of ARION PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 202 897,59 | 194 937,95 | 196 414,03 | 194 256,18 | 115 518,38 | 115 374,83 |
| A. Fixed assets | 7 930,29 | 5 744,37 | 3 388,35 | 0,00 | - | 0,00 |
| B. Current assets | 194 967,30 | 189 193,58 | 193 025,68 | 194 256,18 | 115 518,38 | 115 374,83 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 202 897,59 | 194 937,95 | 196 414,03 | 194 256,18 | 115 518,38 | 115 374,83 |
| A. Equity | -771 903,71 | -777 911,13 | -791 443,53 | -789 002,88 | -863 789,10 | -864 736,99 |
| B. Liabilities and provisions for liabilities | 974 801,30 | 972 849,08 | 987 857,56 | 983 259,06 | 979 307,48 | 980 111,82 |
| I. Long-term liabilities | 400 000,00 | 400 000,00 | 400 000,00 | 952 650,00 | 952 350,00 | - |
| II. Short-term liabilities | 574 801,30 | 572 849,08 | 587 857,56 | 30 609,06 | 26 957,48 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.